Skip to content

Clinical trials

Respiratory Tract Diseases trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Country / region: Singapore Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20173
20181
20192
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting2
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics2
AVEO Pharmaceuticals, Inc.1
Alpha Biopharma (Jiangsu) Co., Ltd.1
Blueprint Medicines Corporation1
Eli Lilly and Company1
Hoffmann-La Roche1
Revolution Medicines, Inc.1
Singapore General Hospital1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases10
Lung Diseases9
Carcinoma, Non-Small-Cell Lung7
Lung Neoplasms7
Neoplasms7
Neoplasms by Site6
Respiratory Tract Neoplasms6
Thoracic Neoplasms6
Bronchial Neoplasms5
Carcinoma4

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.